Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/150632Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Vicente, MM | - |
| dc.creator | Leite-Gomes, E | - |
| dc.creator | Pinho, SS | - |
| dc.date.accessioned | 2023-07-04T15:45:55Z | - |
| dc.date.available | 2023-07-04T15:45:55Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.issn | 1471-4906 | - |
| dc.identifier.uri | https://hdl.handle.net/10216/150632 | - |
| dc.description.abstract | Glycans cover the surfaces of all mammalian cells through a process called glycosylation. Nearly all proteins and receptors that integrate the intricate series of co-stimulatory/inhibitory pathways of the immune system are glycosylated. Growing evidence indicates that the development of the immune system at the origins of T and B cell development is tightly regulated by glycosylation. In this opinion, we hypothesize that the glycome composition of developing T and B cells is developmentally regulated. We discuss how glycans play fundamental roles in lymphocyte development and how glycans early define T and B cell functionality in multiple aspects of adaptive immunity. These advances can provide opportunities for the discovery of novel disease factors and more effective candidate treatments for various conditions. | pt_PT |
| dc.description.sponsorship | This work was funded by the EU (ERC, GlycanSwitch, Grant Agreement N° 101071386). Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council Executive Agency. Funded by the European Union (GlycanTrigger, Grant Agreement N°: 101093997. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. M.M.V. and E.L-G. received funding from the Portuguese Foundation for Science and Technology (FCT) of the Portuguese Ministry of Science, Technology and Higher Education (M.M.V.: PD/BD/135452/2017, COVID/BD/152488/2022; E.L-G.: UI/BD/152866/2022). | pt_PT |
| dc.language.iso | eng | pt_PT |
| dc.publisher | Elsevier | pt_PT |
| dc.relation | info:eu-repo/grantAgreement/FCT/POR_NORTE/PD%2FBD%2F135452%2F2017/PT | - |
| dc.relation | info:eu-repo/grantAgreement/FCT/POR_NORTE/COVID%2FBD%2F152488%2F2022/PT | - |
| dc.relation.ispartofseries | Trends in Immunology | pt_PT |
| dc.rights | openAccess | pt_PT |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
| dc.title | Glycome dynamics in T and B cell development: basic immunological mechanisms and clinical applications | pt_PT |
| dc.type | Artigo em Revista Científica Internacional | pt_PT |
| dc.contributor.uporto | Instituto de Investigação e Inovação em Saúde | pt_PT |
| dc.identifier.doi | 10.1016/j.it.2023.06.004 | - |
| dc.relation.publisherversion | https://www.sciencedirect.com/science/article/pii/S1471490623001126 | - |
| Appears in Collections: | I3S - Artigo em Revista Científica Internacional | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 10.1016-j.it.2023.06.004.pdf | 682.42 kB | Adobe PDF | ![]() View/Open |
This item is licensed under a Creative Commons License
